D. Kimbrough Oller
D. Kimbrough Oller | |
---|---|
Born | Las Vegas, New Mexico, USA | March 31, 1946
Nationality | American |
Alma mater | University of California at Berkeley (BA, 1968), University of Texas at Austin (PhD, 1971) |
Scientific career | |
Fields | Origin of Language phonological development psycholinguistics evolution of language speech and language pathology |
D. Kimbrough Oller (born March 31, 1946) is an American scientist who has contributed to the fields of the evolution of language, child phonology, speech-language pathology (focusing on vocal patterns in cases of infant and childhood hearing loss, Down syndrome, and autism), and to the fields of bilingualism and second-language acquisition. He is currently Professor and Plough Chair of Excellence at the University of Memphis.[1] He is also external faculty member of the Konrad Lorenz Institute for Evolution and Cognition Research[2] (Klosterneuburg, Austria). Oller was elected as a Fellow of the American Speech–Language–Hearing Association (ASHA) in 2004 and was granted the Honors of ASHA in 2013.
In 2011, one of Oller's scientific research articles was recognized by Autism Speaks as one of the top ten achievements in autism.[3] Oller's seminal work on the development of babbling contributed an understanding of how early problems with babbling may be signs of later speech and language disorders.[4] Oller is a permanent member of the Scientific Advisory Board of the LENA Foundation of Boulder, Colorado.[5]
References
- ^ "D. Kimbrough Oller, Ph.D. - School of Communication Sciences and Disorders - University of Memphis". www.memphis.edu. Retrieved 2018-03-08.
- ^ "People | External Faculty | Discover The KLI". www.kli.ac.at. Retrieved 2018-03-08.
- ^ "Top Ten Autism Research Findings of 2010 | Press Release | Autism Speaks". www.autismspeaks.org. 2012-07-25. Retrieved 2018-03-08.
- ^ "Babbling and Early Words - Stages In The Development Of Pre-speech Vocalizations". social.jrank.org. Retrieved 2018-03-08.
- ^ "About | LENA". www.lena.org. Retrieved 2018-03-08.